Skip to main content
. 1998 Mar;111(3):583–587. doi: 10.1046/j.1365-2249.1998.00538.x

Fig. 1.

Fig. 1

Efficacy of passive immunotherapy of influenza A virus pneumonia by i.v. injection of IVIG at doses of 100, 500, 1000 and 5000 μg/mouse (a) or intranasal administration of IVIG at doses of 1, 10, 25, 50 μg/mouse (b) at 3 h after intranasal challenge with the influenza A strain Scotland. Data are the means of two independent experiments, for each route of IVIG administration, using each lot of IVIG, with 10 mice per group in each experiment.